LRRK2 and Parkinson disease: Although the enhanced kinase function of the LRRK2(G2019S) mutant is the prime suspect mechanism for carriers with this mutation to develop PD, the discovery by us and others of LRRK2-dependent phenotypes in kidney suggest that also steady-state abundance of the LRRK2 protein might play a determining role [30], [34].